Healthcare / Medical DevicesTechnical Analysis Guide

MDT Stock Analysis

Medtronic plc

💡 Quick Answer

Across 4 APEX technical signals, MDT is currently split between bullish and bearish readings — 0 bullish, 0 bearish as of 2026-07-08. Run a live analysis to see the current composite score.

MDT is a defensive healthcare trade with low ATR (1.5-2%) and a historically reliable 3%+ dividend yield. It underperforms during risk-on markets and outperforms during defensive rotations.

RSI Behavior: Defensive 40-60 oscillationProcedure Volume: Hospital data is the keyDividend Yield: 3%+ creates floor

Medtronic is the world's largest standalone medical device company, with products spanning cardiac rhythm management, neuromodulation, spine and orthopedics, surgical robotics (Hugo), and diabetes (insulin pumps). After a period of underperformance driven by supply chain issues and surgical procedure volume declines, Medtronic is in an operational turnaround phase focused on margin improvement and new product approvals including its Hugo robotic surgery system.

LIVE CHART·MDT. DailyPowered by TradingView

Open MDT on TradingView ↗Affiliate link

Get live MDT signal analysis

APEX runs 8 signals on MDT in real time: RSI, MACD, Fibonacci, Volume, and more.

Analyze MDT Now →

Why Do Traders Watch MDT?

MDT is a defensive healthcare trade with low ATR (1.5-2%) and a historically reliable 3%+ dividend yield. It underperforms during risk-on markets and outperforms during defensive rotations. Earnings reactions of 3-5% are typical. The stock is sensitive to hospital surgical procedure volumes and the competitive positioning of Hugo versus Intuitive Surgical's da Vinci. Value investors are attracted by its below-sector-average valuation relative to its market position.

Is MDT a Buy Right Now? Current Signal Readings

📊RSI BehaviorDefensive 40-60 oscillation

MDT's RSI oscillates in a narrow defensive range. RSI at 40-42 has historically been an excellent contrarian entry for a 3-4 month hold. The combination of elevated dividend yield and oversold RSI attracts institutional yield-seeking buyers who provide reliable support.

📦Procedure VolumeHospital data is the key

Monthly hospital admissions and elective surgery data. Available from industry trackers before earnings. Are the most reliable leading indicators for MDT. When hospital capacity utilization rises above 75% and elective procedures normalize, MDT beats estimates within 1-2 quarters.

📊Dividend Yield3%+ creates floor

Medtronic's 3%+ dividend yield (a 46-year consecutive growth streak) creates an institutional demand floor. When the yield rises to 3.5%+ due to stock price weakness. With no fundamental deterioration. Income funds historically step in within 1-2 weeks, limiting additional downside.

📊Hugo Robotic SurgeryKey turnaround catalyst

Hugo's regulatory approvals (EU approved, U.S. pending) and hospital system placements are the primary catalyst for MDT's next valuation re-rating. Each major health system choosing Hugo over da Vinci is a meaningful positive signal. Monitor quarterly surgical robotics procedure count disclosures carefully.

📋 MDT Key Stats for Traders

⚡ATR (14-day)1.5-2% of price

📦Avg daily volume~6-10 million shares

📋Dividend yield3%+ (46-year growth streak)

📅Post-earnings move3-5% typical

🔗 Related Stocks

ISRG BSX ABT SYK

Run a live MDT analysis

APEX combines RSI, MACD, Fibonacci, Volume, and 4 more signals into one composite score in under 30 seconds.

Analyze MDT Free →

Advanced charting for MDT on TradingView ↗

💬 Frequently Asked Questions. MDT

QIs MDT a good stock to buy right now?

AWhether MDT is a buy depends on its current technical positioning. MDT is a defensive healthcare trade with low ATR (1.5-2%) and a historically reliable 3%+ dividend yield. It underperforms during risk-on markets and outperforms during defensive rotations. Earnings reactions of 3-5% are typical. The stock is sensitive to hospital surgical procedure volumes and the competitive positioning of Hugo versus Intuitive Surgical's da Vinci. Value investors are attracted by its below-sector-average valuation relative to its market position. Run a live APEX analysis at apexstockintel.com to see the current composite score, RSI, and MACD signals. Updated every trading day.

QWhat are the most important technical signals for MDT?

AThe four key signals for MDT are: RSI Behavior (Defensive 40-60 oscillation). MDT's RSI oscillates in a narrow defensive range. RSI at 40-42 has historically been an excellent contrarian entry for a 3-4 month hold. The combination of elevated dividend yield and oversold RSI attracts institutional yield-seeking buyers who provide reliable support.. Procedure Volume (Hospital data is the key). Monthly hospital admissions and elective surgery data. Available from industry trackers before earnings. Are the most reliable leading indicators for MDT. When hospital capacity utilization rises above 75% and elective procedures normalize, MDT beats estimates within 1-2 quarters.. Dividend Yield (3%+ creates floor). Medtronic's 3%+ dividend yield (a 46-year consecutive growth streak) creates an institutional demand floor. When the yield rises to 3.5%+ due to stock price weakness. With no fundamental deterioration. Income funds historically step in within 1-2 weeks, limiting additional downside.. Hugo Robotic Surgery (Key turnaround catalyst). Hugo's regulatory approvals (EU approved, U.S. pending) and hospital system placements are the primary catalyst for MDT's next valuation re-rating. Each major health system choosing Hugo over da Vinci is a meaningful positive signal. Monitor quarterly surgical robotics procedure count disclosures carefully.

QWhat is MDT's RSI telling traders right now?

AMDT's RSI oscillates in a narrow defensive range. RSI at 40-42 has historically been an excellent contrarian entry for a 3-4 month hold. The combination of elevated dividend yield and oversold RSI attracts institutional yield-seeking buyers who provide reliable support. APEX scores MDT's RSI as part of its 8-factor composite signal. Updated daily.

QHow does MDT behave technically compared to other Healthcare / Medical Devices stocks?

AMDT is in the Healthcare / Medical Devices sector. Medtronic is the world's largest standalone medical device company, with products spanning cardiac rhythm management, neuromodulation, spine and orthopedics, surgical robotics (Hugo), and diabetes (insulin pumps). After a period of underperformance driven by supply chain issues and surgical procedure volume declines, Medtronic is in an operational turnaround phase focused on margin improvement and new product approvals including its Hugo robotic surgery system. Key stats: ATR (14-day): 1.5-2% of price, Avg daily volume: ~6-10 million shares, Dividend yield: 3%+ (46-year growth streak), Post-earnings move: 3-5% typical.

QWhat MACD signals work best for MDT?

AMACD measures momentum direction via the relationship between two exponential moving averages. Bullish crossovers (MACD line crossing above the signal line) indicate increasing upward momentum, while bearish crossovers signal the opposite. APEX tracks MDT's MACD histogram direction daily.

OTHER STOCK GUIDES

Technology49

+−